Our purpose is to update the comprehensive ophthalmologist about the results of the Ocular Hypertension Treatment Study and the current clinical management of ocular hypertension. In the Ocular ...

If you suspect you have this condition, it should be immediately checked. While you can treat ocular hypertension and effectively bring down eye pressure, there is no cure for this condition.

Glaucoma, the leading cause of blindness, is often marked by loss of retinal ganglion cells (RGCs). Necroptosis, a form of ...

In the Ocular Hypertension Treatment Study (OHTS) risk estimator, intraocular pressure is an independent variable and risk of developing glaucoma is the dependent variable. In the Threshold to ...

Bimatoprost is under clinical development by Laboratoires Thea and currently in Phase III for Ocular Hypertension.

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

10, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix ... currently in a Phase 2 clinical trial for the treatment of open-angle glaucoma or ocular hypertension. Follow the Company on its website ...